ASHLEY LANGFORD: Open Payments
NPI 1982331443 · PINEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 30 payments from 10 companies in 2025. Trend: 2023 $13 · 2024 $237 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $183 |
| Teva Pharmaceuticals USA, Inc. | 5 | $93 |
| ABBVIE INC. | 5 | $81 |
| Alkermes, Inc. | 4 | $65 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: HETLIOZ, UZEDY, VRAYLAR, ARISTADA, INGREZZA, REXULTI, INVEGA SUSTENNA, Jornay PM.
Industry payments across KY — which companies pay providers there.
